Frequency of the frame-shifting CYP2D7 138delT polymorphism in a large, ethnically diverse sample population
- PMID: 17494644
- DOI: 10.1124/dmd.107.014993
Frequency of the frame-shifting CYP2D7 138delT polymorphism in a large, ethnically diverse sample population
Abstract
Cytochrome P450 2D7 (CYP2D7) has long been considered a pseudogene. A recent report described an indel polymorphism (CYP2D7 138delT) that causes a frameshift generating an open reading frame and functional protein. This polymorphism was observed in 6 of 12 samples from an Indian population. Individuals with the 138delT polymorphism expressed CYP2D7 protein from a brain-specific, alternatively spliced transcript (J Biol Chem 279:27383-27389, 2004). The unexpectedly high frequency of the variant allele and resulting CYP2D7 expression could have important implications for brain-specific metabolism of CYP2D substrates including many psychoactive drugs. However, the 138delT variant has not been detected in other studies (Pharmacogenetics 11:45-55, 2001; Biochem Biophys Res Commun 336:1241-1250, 2005). Our goal was to determine the frequency of this variant in a larger, ethnically diverse population. CYP2D7 138delT genotypes for 163 Caucasians, 95 East Asians, 50 Indians, 68 Hispanic Latinos, and 68 African Americans were determined by Pyrosequencing. The 138delT allele was observed at a frequency of 1.0% in East Asians and 0.74% in Hispanic Latinos. The deletion was not observed in Indians or the other ethnic populations. In addition, in each of the three samples with 138delT, the putative brain-specific transcript contains a premature stop codon that would preclude protein expression. The low frequency of the CYP2D7 138delT polymorphism in our ethnically diverse sample, and particularly the absence from 50 Indian samples, is in contrast to the high frequency previously reported. Our results suggest that CYP2D7 138delT is unlikely to be highly relevant for population variation of pharmacokinetics or drug response.
Similar articles
-
CYP2D7 splice variants in human liver and brain: does CYP2D7 encode functional protein?Biochem Biophys Res Commun. 2005 Nov 4;336(4):1241-50. doi: 10.1016/j.bbrc.2005.08.255. Biochem Biophys Res Commun. 2005. PMID: 16169517
-
A frameshift mutation and alternate splicing in human brain generate a functional form of the pseudogene cytochrome P4502D7 that demethylates codeine to morphine.J Biol Chem. 2004 Jun 25;279(26):27383-9. doi: 10.1074/jbc.M402337200. Epub 2004 Mar 29. J Biol Chem. 2004. PMID: 15051713
-
Special report: genotyping for cytochrome P450 polymorphisms to determine drug-metabolizer status.Technol Eval Cent Assess Program Exec Summ. 2004 Dec;19(9):1-2. Technol Eval Cent Assess Program Exec Summ. 2004. PMID: 15651132 No abstract available.
-
Unique cytochromes P450 in human brain: implication in disease pathogenesis.J Neural Transm Suppl. 2006;(70):167-71. doi: 10.1007/978-3-211-45295-0_26. J Neural Transm Suppl. 2006. PMID: 17017525 Review.
-
The future of warfarin pharmacogenetics in under-represented minority groups.Future Cardiol. 2012 Jul;8(4):563-76. doi: 10.2217/fca.12.31. Future Cardiol. 2012. PMID: 22871196 Free PMC article. Review.
Cited by
-
Analysis of splicing patterns by pyrosequencing.Nucleic Acids Res. 2009 Oct;37(19):e126. doi: 10.1093/nar/gkp626. Epub 2009 Aug 11. Nucleic Acids Res. 2009. PMID: 19671523 Free PMC article.
-
Expression and functional analysis of CYP2D6.24, CYP2D6.26, CYP2D6.27, and CYP2D7 isozymes.Drug Metab Dispos. 2009 Jan;37(1):1-4. doi: 10.1124/dmd.108.023663. Epub 2008 Oct 6. Drug Metab Dispos. 2009. PMID: 18838503 Free PMC article.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Molecular Biology Databases